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MSH2, associated with MSH3 or MSH6, is a central component of the eukaryotic DNA
Mismatch Repair (MMR) pathway responsible for the recognition and correction of base
mismatches that occur during DNA replication and recombination. Previous studies have
shown that MSH2 plays an additional DNA repair role in response to oxidative damage
in Trypanosoma cruzi and Trypanosoma brucei. By performing co-immunoprecipitation
followed by mass spectrometry with parasites expressing tagged proteins, we confirmed
that the parasites’ MSH2 forms complexes with MSH3 and MSH6. To investigate the
involvement of these two other MMR components in the oxidative stress response,
we generated knockout mutants of MSH6 and MSH3 in T. brucei bloodstream forms
and MSH6 mutants in T. cruzi epimastigotes. Differently from the phenotype observed
with T. cruzi MSH2 knockout epimastigotes, loss of one or two alleles of T. cruzi
msh6 resulted in increased susceptibility to H2O2 exposure, besides impaired MMR. In
contrast, T. brucei msh6 or msh3 null mutants displayed increased tolerance to MNNG
treatment, indicating that MMR is affected, but no difference in the response to H2O2
treatment when compared to wild type cells. Taken together, our results suggest that,
while T. cruziMSH6 and MSH2 are involved with the oxidative stress response in addition
to their role as components of the MMR, the DNA repair pathway that deals with oxidative
stress damage operates differently in T. brucei.
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INTRODUCTION
Chagas disease (or American trypanosomiasis) and African Sleeping Sickness (or Human African
trypanosomiasis—HAT) are two important endemic and neglected zoonoses caused by parasites
of the trypanosomatidae family, respectively called Trypanosoma cruzi and Trypanosoma brucei.
About 6–7 million people worldwide are estimated to be infected with T. cruzi. Although Chagas
disease is endemic in Latin American countries, it has become a global health concern due to
migration flows to Europe, United States, Canada and Japan (Antinori et al., 2017; WHO, 2019a).
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Besides infecting humans, T. brucei infects animals, including
cattle, causing a form of the disease named Nagana (or African
Animal Trypanosomiases-AAT) that has a major economic
impact for the livestock industry in east and southern Africa
(Isaac et al., 2017). Human African Trypanomiasis is caused
by Trypanosoma brucei gambiense or Trypanosoma brucei
rhodesiense and is frequently fatal if not treated (WHO, 2019b).
Both parasites have digenetic life cycles that involve an
invertebrate host—a triatomine bug infected with T. cruzi,
or a tsetse fly infected with T. brucei—and a mammalian
host. Inside the digestive tract of the triatomine bug, T. cruzi
multiplies as epimastigotes before differentiating into infective,
non-replicative metacyclic trypomastigotes. After a blood meal,
metacyclic trypomastigotes are expelled with the vector’s feces.
During a bite, eliminated parasites can enter the bloodstream
when the host scratches the skin area, or through mouth
mucosa, eyes and nose. Although less frequent, human infection
may also happen by non-vectorial routes such as ingestion of
contaminated food, blood transfusion, organ transplantation,
or during pregnancy from contaminated mothers (Cevallos
and Hernández, 2014; Santana et al., 2019). Circulating
trypomastigotes can invade different cell types, where they
replicate as intracellular replicative amastigotes that burst the
cell and are released into the bloodstream with the potential to
infect new cells (Brener, 1973). Similar to T. cruzi, T. brucei has a
complex life cycle in which it has to adapt to the host bloodstream
and different compartments of the tsetse fly, such as the midgut
after a bloodmeal and then the salivary gland before transmission
to a newmammalian host. Two replicative forms are most readily
cultured in vitro: procyclic form (PCF), found in the insect vector,
and bloodstream form (BSF) present in the mammalian host.
Because of this experimental accessibility, most genetic analyses
have focused on T. brucei BSF and PCF (Matthews, 2005).
To maintain their genome integrity, while adapting to survive
in distinct and often hostile environments, trypanosomatids
rely on various DNA repair pathways that act in response to
different types of DNA damage (Machado-Silva et al., 2016).
One such pathway is the DNA Mismatch Repair (MMR)
pathway, which is the main pathway, widely conserved from
prokaryotes to eukaryotes, that corrects replication errors that
escape the proofreading activity of replicative DNA Polymerases
(Li, 2008). Besides recognizing non-Watson-Crick base pairing,
MMR also acts on insertion/deletion loops (IDLs), as well as
on DNA damage caused by endogenous agents such reactive
oxygen species (ROS) derived from cell metabolism, hydrolytic
and oxidative reactions with water or exogenous sources, for
example UV and ionizing radiations, alkylating agents, and
crosslinking agents (Edelbrock et al., 2013). In eukaryotes, MMR
initiates by the recognition of DNA mispairing by the partially
redundant MSH2-MSH6 (MutSα) and MSH2-MSH3 (MutSβ)
heterodimers, which are homologous to the bacterial MutS
homodimer. MutSα recognizes single base pair mismatches and
1–2 base insertion/deletion loops (IDLs), while MutSβ primarily
recognizes larger IDLs. When MSH2-MSH6 or MSH2-MSH3
binds to mispaired bases, a ring is formed around the DNA, with
the DNA binding domain of MSH6 or MSH3 making contact
with both the mispaired base and adjacent sites of the DNA.
This binding results in DNA bending (Kumar et al., 2011), which
works as a “double check” before DNA repair is initiated (LeBlanc
et al., 2018). In addition to their DNA binding domains, MSH
proteins also have an ATP binding domain. ATP activation is
required for downstream events leading to DNA repair. The
lesion detected by MSH proteins is repaired through enzymatic
complexes that make an endonucleolytic cut on the newly
synthesized strand. The ATP-activated MSH complex recruits
MLH/PMS heterodimers that are homologs of bacterial MutL
proteins. Together with accessory factors including PCNA, RFC,
RPA, and exonuclease 1 (ExoI), MLH/PMS initiate the excision
of the error-containing strand. Upon removal, the segment is re-
synthesized by DNA polymerase delta and ligation by DNA ligase
I restores a corrected DNA duplex (Kim et al., 2018).
Besides their primary role in MMR, eukaryotic MMR
proteins are involved in diverse cellular processes such as
homologous recombination (HR) (Spies and Fishel, 2015), triplet
repeat expansion (Iyer et al., 2015), somatic hypermutation of
immunoglobulins (Pilzecker and Jacobs, 2019) and cell signaling
(Gupta and Heinen, 2019). MMR proteins activate cell cycle
checkpoints and cell death pathways in response to certain DNA
lesions, an additional role in the DNA damage response that can
trigger cell cycle arrest and apoptosis (Li et al., 2016). Because of
their importance in genome maintenance, mutations that cause
loss of function in different MMR genes have been associated
with predisposition to various types of cancer (Lee et al., 2016).
Genome sequence analyses revealed that T. cruzi and T. brucei
possess a complete set of MMR proteins, indicating that these
organisms have a functional MMR pathway composed of
homologs of MSH2, MSH3, and MSH6 (originally named MSH8
in T. brucei) (Bell et al., 2004), MLH1 and PMS1 (Passos-Silva
et al., 2010). However, no homolog for MSH1, which is the
MutS homolog involved with the repair of mitochondrial DNA,
including oxidative damage (Kaniak et al., 2009; Pogorzala et al.,
2009; Foyer, 2018), has been identified in these organisms. We
have previously investigated the role of the MSH2 and MLH1
components of the MMR pathway in T. cruzi and T. brucei
by generating knockout mutants in different life cycle forms
of these parasites (Bell and McCulloch, 2003; Machado-Silva
et al., 2008; Campos et al., 2011; Grazielle-Silva et al., 2015).
Because T. cruzi and T. brucei are exposed to several sources of
oxidative stress during their life cycle and, among the different
antioxidant defense mechanisms these parasites have evolved to
protect genomic and mitochondrial DNA from oxidative lesions
is the MMR pathway, we began investigating the role of MSH2
in response to the oxidative stress in both parasites (Machado-
Silva et al., 2016). T. brucei msh2 null mutants show increased
tolerance to MNNG exposure, a phenotype characteristic of
MMR impaired cells (Bell et al., 2004; Grazielle-Silva et al., 2015).
In addition, in T. brucei bloodstream forms, the lack of TbMSH2
resulted in increased susceptibility to H2O2 exposure (Machado-
Silva et al., 2008; Campos et al., 2011). Complementation of the
TbMSH2 null mutant with T. cruzi MSH2 restores the oxidative
stress response, but not MMR impairment as suggested by
the response to MNNG treatment and microsatellite instability
(MSI) assays (Machado-Silva et al., 2008). These experiments
provided the first line of evidence indicating that T. cruzi MSH2
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acts in response to the oxidative stress in a pathway or a signaling
process that is independent of canonical MMR pathway. To
better investigate this new role of MSH2 in response to oxidative
damage in DNA, we have also tested a T. brucei mlh1 null mutant,
which showed impaired MMR, but no defect in the oxidative
stress response (Bell et al., 2004; Machado-Silva et al., 2008;
Grazielle-Silva et al., 2015). T. cruzi heterozygousmsh2 knockout
mutants have increased susceptibility to oxidative stress caused
by H2O2 and accumulate more 8-oxo-guanine in genomic and
mitochondrial DNA after H2O2 exposure (Campos et al., 2011)
but, surprisingly, deletion of the two msh2 alleles in T. cruzi
epimastigotes resulted in increased tolerance to oxidative damage
caused by H2O2. Similarly,msh2 knockout generated in T. brucei
PCF also presented increased tolerance to H2O2 treatment. These
results have led us to propose that an adaptation mechanism to
cope with the loss of MSH2 took place in the insect stages of these
mutant parasites, i.e., T. brucei PCF and T. cruzi epimastigotes,
allowing them to deal with the oxidative stress in the absence
of this protein (Grazielle-Silva et al., 2015). Here, we investigate
the involvement of other MMR components in the oxidative
stress response by analyzing the effect of various DNA damaging
treatments on T. brucei and T. cruzi msh3 or msh6 knockout
cell lines. Our main goal was to verify whether the previously
observed response to oxidative stress involving MSH2 is part of a
DNA damage response that works independently of MMR, or if
other MMR proteins act together with MSH2 to repair oxidative
damage in a non-canonical DNA repair pathway.
METHODOLOGY
Parasite Cultures
T. brucei cultures of the Lister 427 strain bloodstream
(BSF) form were maintained at 37◦C, 5% CO2 in HMI-
9 (GIBCO) medium supplemented with 20% fetal bovine
serum (GIBCO). Cell passages were performed every 48 h,
with population density maintained between 1 × 105 and
2 × 106 cells/mL. Epimastigotes of the CL Brener clone
of T. cruzi were maintained in logarithmic growth phase at
28◦C in liver infusion tryptose (LIT) medium supplemented
with 10% fetal bovine serum (GIBCO) and penicillin (10,000
U/mL)/Streptomycin (10,000µg/mL) (GIBCO) as described
(Camargo, 1964). Metacyclic trypomastigotes, obtained after
metacyclogenesis of epimastigote cultures maintained in LIT
medium for 15–20 days, were used to infect Vero cells cultured
in high-glucose DMEM medium (GIBCO) supplemented
with 5% fetal bovine serum (GIBCO) and penicillin (10,000
U/mL)/Streptomycin (10,000µg/mL) (GIBCO).
Plasmid Constructs to Generate Knockout
and Tagged Parasites
Knockout constructs prepared to delete msh3 (TritrypDB
Tb427tmp.160.3760) or msh6 (TritrypDB Tb427.10.6410) in
T. brucei BSF cells have minor changes in their designs relative
to those used before for msh2 and mlh1 knockout (Grazielle-
Silva et al., 2015). The knockout constructs were generated by
PCR-amplifying the 5′ and 3′ UTRs of the gene of interest from
T. brucei Lister 427 genomic DNA. PCR amplified fragments
containing the 5′ and 3′ UTRs from msh3 and msh6 were cloned
into the knockout construct. These constructs were linearized
with SacI and XhoI and used for transfection of T. brucei BSF
as described below. T. brucei BSF and PCF were also transfected
with constructs to tag MSH2 and MSH6 C-terminally in their
endogenous locus. Primers complementary to the C-terminal
region of msh2 CDS were used to generate an amplicon that
was cloned into the plasmid pNAT12myc (Alsford and Horn,
2008) resulting in the msh2 CDS fused to 12 repeats of the c-
myc epitope. Similarly, primers complementary to a C-terminal
region of msh6 CDS were designed to generate a fragment with
the msh6 CDS in frame with six repeats of the hemagglutinin
(HA) epitope derived from the T. brucei pTbMCM-HA plasmid
(Tiengwe et al., 2012).
To generate T. cruzi epimastigotes with the two msh6
alleles deleted, we used a donor plasmid containing the
Neomycin phosphotransferase gene (Neo) or Hygromycin
B phosphotransferase gene (Hygro) flanked by intergenic
sequences of the HX1 and GAPDH regions derived from the
pROCK_GFP vector (DaRocha et al., 2004). To generate the
donor sequence named TcMSH6_HX1_Neo_GAPDH_MSH6,
Tcmsh6 coding region previously cloned in the pCR R© TOPO
2.1 (Thermo Fisher Scientific) was digested with SacII and
XmnI and ligated with T4 DNA ligase into the construct
named HX1_Neo_GAPDH (Grazielle-Silva et al., 2015). The
donor sequence MSH6_HX1_Neo_GAPDH_MSH6 was PCR-
amplified and used together with the ribonucleoprotein (RNP)
complex formed by recombinant Cas9 (rCAS9) and two sgRNAs
that recognizes the 5′and 3′ portions of Tcmsh6 CDS for
transfection of T. cruzi CL Brener clone. To generate parasites
resistant to Neomycin and Hygromycin in which the two alleles
of Tcmsh6 were deleted, another round of transfection was
performed using the RNP complex described above and the
donor sequence named MSH6_HX1_Hygro_GAPDH_MSH6.
The donor sequence with the Hygro gene was constructed
after digesting the Topo_HX1_Hygro_GAPDH plasmid, in
which the insert was cloned in the reverse orientation, with
KpnI and EcoRV. The fragment of interest was cloned in
the pGEM_TcMSH6 vector previously digested with ClaI
and KpnI. This construction was designed in a way that
HX1_Hygro_GAPDH disrupts Tcmsh6 CDS.
To generate T. cruzi msh6 knockouts complemented with
msh6, two knockout clones (cl1 and cl2) were transfected with
the pTREX plasmid (Vazquez and Levin, 1999) containing the
MSH6 fused to an HA tag and the puromycin resistance gene. A
PCR fragment with themsh6 CDS and six in frame repeats of the
HA epitope and the restriction enzymes SpeI andXhoI was cloned
into the pTREX_GFP-PAC plasmid digested with XbaI and XhoI.
Three days after transfection the parasite populations growing in
medium with 15µg/mL of puromycin were tested by Western
blot and treatments with MNNG and H2O2.
To evaluate the cellular localization of MSH6, T. cruzi
epimastigotes were transfected with amodified version of pTREX
plasmid (Vazquez and Levin, 1999) to express MSH6 fused
to the monomeric red fluorescent protein (mRFP). The msh6
CDS without the stop codon was amplified with primers that
also added the restriction sites for XbaI and SmaI to the
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PCR fragment. After digestion, this fragment was cloned into
pTREX_mRFP giving origin to pTREX_MSH6_mRFP. To C-
terminally tag MSH6 at its endogenous locus, primers were
generated against a C-terminal region of msh6 CDS excluding
the stop codon. This fragment was cloned into pCR R© TOPO 2.1
(Thermo Fisher Scientific) in frame with the six repeats of the
HA epitope derived from the T. brucei pTbMCM-HA plasmid
(Tiengwe et al., 2012). As a selective marker, neomycin resistance
gene derived from the pROCK_Neo plasmid (DaRocha et al.,
2004) was also cloned in the same pCR R© TOPO 2.1 (Thermo
Fisher Scientific) vector. The construct was linearized with KpnI
and used to transfect T. cruzi epimastigotes.
Primers used to generate knockout constructions, plasmids
to express tagged proteins and to evaluate the correct insertion
of knockout constructions in the genome are listed in
Supplementary Table 1.
T. brucei Transfection
Transfection of T. brucei BSF was performed using the AMAXA
Nucleofactor kit (Amaxa Biosystems) and the X-001 programme.
Cultures were grown to a density of 1 × 106 cells/mL and
around 4 × 107 cells were used per transfection with 5–10 µg
of linearized DNA, as previously described (Burkard et al., 2007).
T. cruzi Transfection With Recombinant
Cas9
Transfection to generate T. cruzi knockout cells using the
CRISPR/Cas9 system were performed as previously described
(Burle-Caldas et al., 2018). Briefly, Cas9/sgRNAs RNP complex
plus a donor sequence composed of Tcmsh6 CDS replaced by
the resistance gene construction HX1_Neo_GAPDH (named
MSH6_HX1_Neo_GAPDH_MSH6) were used to transfect
T. cruzi epimastigotes from the CL Brener cloned strain.
Recombinant Cas9 derived from Staphylococcus aureus and
two sgRNAs that were transcribed in vitro formed the
ribonucleoprotein (RNP) complex that was transfected together
with the donor cassette with the Tb-BSF buffer (Schumann
Burkard et al., 2011) and the Amaxa Nucleofector (Lonza)
program U-033. After one pulse, parasites were cultivated in
LIT medium with 200µM G418 (GIBCO). After selection
of G418 resistant parasites, another round of transfection
was performed as described above using the donor sequence
MSH6_HX1_Hygro_GAPDH_MSH6 and selection with 200µM
Hygromicin B (Thermo Fisher).
Cellular Localization
T. cruzi expressing MSH6 fused to mRFP or to 6x HA epitopes
were fixed with 4% paraformaldehyde for 5min, permeabilized
with 0.1% Triton X-100 for 10min, blocked with 1% BSA, 0.2%
Tween 20 for 1 h at room temperature and incubated with
1:500 anti-HA antiserum (Roche) for 1 h. After washing with
PBS, nuclei were stained with 1µg/mL of DAPI (Molecular
Probes/ Life Technologies) for 5min and cover slides mounted
with prolong gold anti-fade solution (Molecular Probes/Life
Technologies). Images were acquired with a 100x objective
in the fluorescence microscope Olympus BX60 microscope
using Q-color 5 digital camera and Qcapture Pro 6.0 software
and with Nikon Eclipse Ti Tecnai G2-12 SpiritBiotwin FEI
(120kV) at the Centro de Aquisição e Processamento de
Imagens (CAPI-ICB/UFMG).
Immunoprecipitation of MMR Components
Pulldown of TbMSH2with c-myc tag was performed as described
(Tiengwe et al., 2012). Briefly, 109 cells of T. brucei BSF or
PCF co-expressing TbMSH2 fused to c-myc tag (TbMSH2::myc)
and MSH6 fused to HA tag (MSH6::HA) were lysed in lysis
buffer (50mM Hepes [pH7.55]; 100mM NaCl; 1mM EDTA
[pH8.0]; 10% glycerol; 1% Triton X-100) for 2 h at 4◦C and
incubated with anti-myc antibody (Milipore) previously bound
to Dynabeads M-280 Sheep Anti-Mouse IgG (ThermoFisher) for
2 h at 4◦C. After five washing steps with wash buffer (50mM
Hepes [pH7.55]; 100mM LiCl; 1mM EDTA [pH8.0]; 1mM
EGTA; 0,7% Na Deoxycolate; 1% NP-40) and one step washing
with TE wash buffer (10mM Tris [pH8.0], 1mM EDTA [pH8.0];
50mM NaCl), beads were collected using a magnetic rack and
bound protein with its binding partners released in elution buffer
(50mM Tris [pH8.0], 10mM EDTA [pH8.0]; 1% SDS). Samples
(input and pulldown) were analyzed by SDS-polyacrylamide gel
electrophoresis and Western blotting with anti-myc antibody
against the pulled down TbMSH2 and with anti-HA antibody
against TbMSH6.
T. cruzi immunoprecipitation was performed after lysing
epimastigotes WT and transfected parasites co-expressing MSH6
fused to HA tag (MSH6::HA) and MSH2 fused to c-myc tag
(MSH2::myc) in RIPA buffer (0 5mM Tris-HCl pH 8.; 15mM
NaCl; 0,1%NP-40, 0.05%Deoxicolato de sódio, 0.01% SDS). After
lysis, cell extracts were centrifuged 8,2,000 × g for 10min and
the supernatant incubated with EZview Red Anti-HA Affinity
Gel (Sigma—Aldrich) at 4◦C under soft agitation for 16 h. Ten
percentage of cell lysate (input fraction) were transferred to
a new tube and saved for further western blot analysis. After
incubation period beads were centrifuged 8,2,000 × g for 1min
and unbound proteins, present in the supernatant, transferred
to new tube. Beads were washed five times with lysis buffer
and bound proteins eluted in elution buffer (62,5mM Tris-
HCl pH 6,8; 10% glycerol; 2% SDS; 5% β-mercaptoethanol;
0,002% bromophenol blue). Samples were analyzed by SDS-
polyacrylamide gel electrophoresis and Western blotting with
anti-HA antibody against the pulled down TcMSH6 and with
anti-myc antibody against TcMSH2.
Parasite Treatment With Genotoxic Agents
T. brucei BSF cultures were inoculated in HMI-9 medium
(Hirumi and Hirumi, 1994) at density of 1 × 105 cells/mL. The
conversion of Alamar blue to fluorescent Resazurin (Räz et al.,
1997) was used to determine the sensitivity of T. bruceiWT cells
and Tbmsh3 and Tbmsh6mutants towardMNNG. Briefly, 200µl
of 1 × 105cells/mL cultures were plated on polystyrene 96 well-
plates in the presence of medium containing doubling dilutions
of MNNG from 400 to 0.39µM. After 48 h, 20 µl of Resazurin
(0.125 mg/mL) was added to each well. Cultures were allowed to
grow for another 24 h and then florescence was measured using
luminescence spectrometer (LS 55, Perkin Elmer) at an emission
wavelength of 590 nm. IC50 values was calculated using Prism
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(GraphPad). For treatment with H2O2 BSF cells were diluted to
1 × 106 cells/mL in HMI-9 medium and incubated with 100µM
H2O2 (VWR) at 37◦C, 5%CO2 for 72 h. After growth, cell density
was measured using a haematocytometer.
WT T. cruzi epimastigotes and msh6 mutants in the
exponential growth phase were counted and diluted to 1 × 107
cells/mL in LIT medium in the absence or presence of 5µM
MNNG (Tokyo chemical industry Ltd). After 72 h cell densities
were determined by counting live cells with a haematocytometer
using Erythrosin B exclusion and plotted as the percentage
survival of the MNNG treated cells relative to untreated cultures.
For treatment with H2O2, T. cruzi epimastigotes were incubated
in 100µM H2O2 for 30min in PBS 1x, after which H2O2
containing PBS was removed and cells allowed to grow in
LIT medium for 72 h. Cell viability was determined with a
haematocytometer using Erythrosin B exclusion and plotted as
percentage survival of the treated cells relative to untreated.
Similar to described above, T. cruzi msh6 knockouts transfected
with pTREX_MSH6::HA_PAC were treated with 5µM MNNG
and 100µM H2O2. 72 h after drug incubation cell numbers
were determined with a haematocytometer using Erythrosin B
exclusion and plotted as the percentage survival.
DNA Sequencing
Two different clones of T. cruzi msh6 CDS amplified by PCR and
cloned in the pCR R© TOPO 2.1 (Thermo Fisher Scientific) were
selected for DNA sequencing by capillary electrophoresis using
an ABI Prism 3730 Genetic Analyzer (Applied Biosystems). Four
different primers were used to cover the completemsh6 sequence.
Cell Infection
Vero cells were infected with T. cruzimetacyclic trypomastigotes
and maintained at 37 ◦C in a humidified atmosphere containing
5% CO2 until trypomastigotes were released in the supernatant.
These trypomastigotes were counted using a haemocytometer
and an equal number of WT and two msh6 null mutant clones
were used to infect Vero cells or macrophages harvest from
Balb/C mice after thioglycollate injection, previously adhered
to 13mm glass coverslips inside 24 wells-plates. At a MOI
of 5 parasites per cell, trypomastigotes were allowed to infect
cells for 2 h after which non-internalized trypomastigotes were
removed. Time points 24 and 48 h after infection were fixed and
stained with panoptic. Five hundred uninfected and infected cells
counted in random fields. Intracellular amastigotes of infected
cells were also counted. The data was represented by the infection
index= percentage of infected cells×mean number of parasites
per infected cells.
Statistical Analyses
Statistical analyses in this work were performed using the
GraphPad Prism version 7.00 for Mac OS X, GraphPad Software,
La Jolla California USA, www.graphpad.com. Data are presented
as mean plus standard deviation, and all experiments were
repeated at least three times. Results were analyzed for significant
differences using ANOVA followed by Bonferroni post-test.
Statistical tests used are described at each figure legend. The level
of significance was set at P < 0.05.
RESULTS
MSH2 Forms Heterodimers With MSH3 and
MSH6
Previous studies have shown that T. cruzi and T. brucei MSH2
are involved in the oxidative stress response to DNA damage
(Grazielle-Silva et al., 2015). To investigate the mechanisms
behind this additional role of MSH2 we searched for proteins
that may interact with MSH2 by tagging T. brucei MSH2
with the myc epitope and performing immunoprecipitation. As
shown in Figure 1A, T. brucei MSH2::myc forms a complex
with MSH6 in BSFs co-expressing HA-tagged MSH6. Protein
bands identified after SDS-PAGE of the immunoprecipitated
fraction obtained from cells co-expressing MSH2::myc and
MSH6::HA, but not from WT BSFs, were sent for protein
sequencing and identification using mass spectrometry. As
shown in Figure 1B, the two major bands present in the
immunoprecipitated pellet were identified as MSH2 and MSH3.
Similarly, PCFs expressingMSH2with themyc epitope were used
for immunoprecipitation with anti-myc antibody as shown on
western blot in Figure 1C. Mass spectrometry analyses of the
proteins present in the two bands shown in Figure 1D showed
that, in transfected PCF parasites, but not in WT cells, MSH3
co-immunoprecipitated with myc-tagged MSH2 (Figure 1D).
Supplementary Table 2 shows identified proteins and peptide
sequences obtained after mass spectrometry. Similar to the data
obtained in T. brucei, immunoprecipitation of cell extracts from
T. cruzi epimastigotes co-expressing MSH6::HA and MSH2::myc
showed the presence of the MSH2-MSH6 complex (Figure 1E).
In conclusion, these analyses showed thatMSH2 forms a complex
with both MSH3 and MSH6 in T. brucei BSFs. In T. brucei
PCFs we identified a complex containing MSH2 and MSH3,
and in T. cruzi epimastigotes MSH2 was found to interact
with MSH6.
T. brucei msh6 and msh3 Null Mutants
Present a Similar Response to Oxidative
Stress When Compared to Wild Type
Parasites
The first step during DNA error recognition by the eukaryotic
MMR is performed by heterodimers formed between MSH2 and
MSH6, named MutSα, or MSH2 and MSH3, named MutSβ.
We showed that both complexes are formed in T. brucei and,
as described previously, that MSH2 is involved in the response
to oxidative damage in DNA. Since we have also evidences
indicating that MSH2 works independently from downstream
effector proteins, like MLH1, in the response to oxidative damage
(Grazielle-Silva et al., 2015), it is possible that such activity is
part of a non-canonical MMR pathway. To test the possibility
that MSH2 is the only protein of the MMR pathway responsible
for the recognition of oxidative damage, we generated T. brucei
BSF and PCF mutants with deleted msh3 or msh6. Tbmsh6
and Tbmsh3 knockouts were obtained by disrupting their
coding sequences (CDS) with constructs containing blasticidin
or puromycin drug resistance genes flanked by tubulin and actin
intergenic regions to provide SL addition and poly-A processing
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FIGURE 1 | Interaction of MSH2 with MSH6 and MSH3 in T. brucei and T. cruzi. (A) Cell extract of T. brucei BSF wild type (WT), BSF expressing MSH2 with a myc tag
(MSH2::myc) and BSFs co-expressing MSH2::myc and MSH6 with an HA tag (MSH6::HA) were used for co-immunoprecipitation with α-myc antibody bound to
magnetic beads. Western blot of input and precipitated (IP) fractions were incubated with α-myc (1:7,000) or α-HA (1:5,000) antibodies. (B) Polyacrylamide gel
electrophoresis stained with Brilliant Blue G showing protein bands present on the IP fraction described in Figure 1A. The bands identified in MSH2:myc/MSH6::HA
expressing parasites but not on WT BSFs were cropped and sent for mass spectrometry. Black arrows show identified MSH2 and MSH3 proteins. (C) Cell extract of
T. brucei PCF WT and PCF expressing MSH2::myc were used to immunoprecipitate MSH2 with α-myc. The IP fraction as well as the unbound and input fractions
were analyzed on western blot with anti-myc antibodies. In addition to MSH2, a 50 KDa band corresponding to immunoglobulin heavy chain is identified in the IP
fraction. (D) IP fractions from WT and PCF expressing MSH2::myc were separated on polyacrylamide gel electrophoresis stained with Brilliant Blue G. The two bands
present in the IP fraction of MSH2::myc expressing cells but not on WT PCFs were cropped and sent to mass spectrometry. Arrows show identified MSH2 and MSH3
proteins. (E) Cell extract of T. cruzi epimastigote WT and epimastigotes transfected to co-express MSH2::myc and MSH6 with an HA tag (MSH6::HA) were used for
co-immunoprecipitation with α-HA antibody. Western blot of input and precipitated (IP) fractions were incubated with α-HA (1:3,000) or α-myc (1:3,000) antibodies.
signals. After transfection, clones resistant to blasticidin and
puromycin were tested by PCR to confirm gene disruption
(Supplementary Figure 1). As shown in Figure 2, PCR analyses
of cDNAs generated from RNA isolated from WT and drug
resistant parasites using primers that bind specifically to the
Tbmsh3 or Tbmsh6 CDSs showed no expression of msh3
or msh6 mRNAs in knockout parasites (Figures 2A,B). PCR
reactions performed with RNA samples that were not previously
incubated with Reverse Transcriptase generated no products,
except with control DNA (Figure 2C). To attest the quality of
the cDNAs produced from all samples, the Tbrad51 CDS was
amplified with specific primers, generating the expected PCR
products (Figure 2D).
A phenotype frequently associated with MMR impairment is
increased tolerance to MNNG exposure (de Wind et al., 1995).
Using the alamar blue assay to determine cell viability after
treatment of WT and T. brucei knockout mutants with MNNG,
we showed that, while Tbmsh6 null mutants are more resistant
to MNNG exposure compared toWT cells, Tbmsh3 null mutants
have no alteration regarding tolerance to MNNG (Figure 3A).
To verify whether Tbmsh3 or Tbmsh6 null mutants respond
differently to oxidative stress, T. brucei WT BSF and Tbmsh6
or Tbmsh3 mutants were grown in culture media containing
0, 50, or 100µM H2O2 and parasite survival determined 72 h
later. As shown in Figure 3B, distinct from the results previously
described with Tbmsh2 null mutants (Machado-Silva et al., 2008;
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FIGURE 2 | RT-PCR analysis of BSF msh3 and msh6 mutants. Agarose gel electrophoresis of PCR products generated after reverse transcriptase (RT) reactions of
RNA isolated from T. brucei BSFs msh3 and msh6 knockout mutants (-/-), WT cells and heterozygous (+/-) mutants. (A) PCR products generated with cDNA from
WT and Tbmsh3 mutants and primers that amplify part of msh3 CDS with an expected fragment of 437 bp. (B) PCR with cDNA from Tbmsh6 mutants and primers
that amplify part of msh6 CDS with an expected fragment of 502 bp. (C) PCR with RNA samples in the absence of RT isolated from wild type and mutants and
TbRAD51 primers; gDNA from WT T. brucei was used as a positive control for the reaction, and blank is a control PCR with water instead of a DNA template.
PCR-amplification has the expected size 1,122 bp. (D) PCR products from cDNA samples derived from RNA isolated from samples as shown in (C) and amplified
with Tbrad51 primers. PCR-amplification has the expected size 1,122 bp.
FIGURE 3 | Evaluation of MMR deficiency in T. brucei msh3 and msh6 knockouts. (A) The conversion of Alamar blue to fluorescent Resazurin was used to determine
the sensitivity of T. brucei WT cells and Tbmsh3 and Tbmsh6 mutants toward MNNG and shown by IC50 values. IC50 values are the mean of three experiments. (B)
Susceptibility of T. brucei MMR knockout mutants to the oxidative stress caused by H2O2. WT, Tbmsh3+/-, Tbmsh3-/-, Tbmsh6+/-, and Tbmsh6-/- were grown in
culture media containing 0, 50, or 100µM H2O2. Cell densities were counted 72 h after incubation beginning. Values are shown as percentage survival, which was
calculated from the cell density of each cell type in the presence of H2O2 as a percentage of the same cells grown in the absence of damage (which was taken as
100%). Vertical lines show standard deviation. **p < 0.01: determined by one-way ANOVA with Bonferroni post-test of knockout mutants relative to WT cells. Ns
indicates no significant difference.
Grazielle-Silva et al., 2015), no changes in the susceptibility to
H2O2 of Tbmsh3 or Tbmsh6 knockout cells were observed when
compared to WT parasites.
T. cruzi MSH6, Encoded by a Heterozygous
Single-Copy Gene, Localizes to the
Nucleus
Analyses of the T. cruzi and T. brucei genomes have shown
that msh6 is present as a single-copy gene in both parasites
(Berriman et al., 2005; El-Sayed et al., 2005). Because CL Brener,
the T. cruzi reference strain, is a hybrid strain, most genes have
been assigned to one of the two haplotypes, named Esmeraldo
and Non-Esmeraldo, that compose the CL Brener genome (El-
Sayed et al., 2005). When we searched formsh6 in the CL Brener
genome database (available at https://tritrypdb.org) we identified
only one sequence annotated as belonging to the non-Esmeraldo
haplotype. However, during our initial attempts to generate a
Tcmsh6 null mutant using donor sequences with homology to
Tcmsh6 flanking a drug resistance marker, we observed that
only clones with a single deleted allele were generated. This
result prompted us to investigate whether the CL Brener genome
contains two alleles instead, with sequences that are different
enough to prevent homologous recombination with the same
donor sequence. To test this hypothesis, we amplified the msh6
locus using primers annealing at the beginning and the end of
msh6 CDS and cloned the PCR product into pCR R© TOPO 2.1
(Thermo Fisher Scientific). By sequencing plasmid DNA from
different clones, we verified that the DNA sequence for Tcmsh6
currently annotated in the T. cruzi CL Brener genome database
represents a hybrid between the Esmeraldo-like and Non-
Esmeraldo-like alleles (Supplementary Figure 2A), a frequent
error that occurred during the assembly process (Daniella
Bartholomeu, personal communication). Based on the PCR
sequences, we concluded that the Tcmsh6 has two alleles that
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present 94.2% homology at the nucleotide level and the translated
product generates two distinct protein isoforms presenting 96.9%
amino acid identity (Supplementary Figure 2B). To confirm the
results from our sequence analyses, we digested the PCR products
corresponding to Tcmsh6 CDSs with the enzyme NarI. As shown
in the upper panel of Figure 4A, according to its sequence, the
Esmeraldo-like msh6 allele has the NarI restriction site whereas
the non-Esmeraldo allele cannot be digested byNarI. Agarose gel
electrophoresis of the digested products showed two fragments
with 1,318 and 1,691 bp corresponding to the Esmeraldo-like
allele, and one fragment with the expected size (3,009 bp) of
the non-digested Non-Esmeraldo-like allele (Figure 4B). Thus,
contrary to the data currently available in the CL Brener genome
database, this T. cruzi strain contains two distinct msh6 alleles,
FIGURE 4 | Characterization of T. cruzi MSH6. (A) A recognition site for the restriction enzyme NarI (highlighted in blue) is present in the DNA sequence for the
Esmeraldo-like allele but is absent in the Non-Esmeraldo-like allele of the msh6 gene in the CL Brener clone. Non-conserved nucleotides are shown in pink. (B) Left
panel shows that PCR amplified CDS of the Esmeraldo-like allele after digestion with NarI, resulting in DNA fragments of 1,318 bp and 1,691 bp, while the
non-digested fragment corresponding to Tcmsh6 CDS has 3,009 bp. Black arrows denote primer binding site. Agarose gel electrophoresis of the PCR product from
amplified Tcmsh6 CDS not digested (ND) and digested (D) with NarI. (C) Epimastigotes transfected with the pTREX_MSH6::mRFP were analyzed under fluorescence
microscopy. Parasite nucleus and kinetoplast DNA are stained with DAPI (upper panel). Parasites transfected with a plasmid that inserts an HA tag in the msh6 locus
were analyzed by immunofluoresce after stained with anti-HA antibody (1:50) and anti-rat conjugated with Alexa 488 (1:100). Parasite nucleus and kinetoplast DNA
are stained with DAPI (lower panel). (Bar = 5µM).
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which can be distinguished by the presence/absence of a NarI
restriction site.
By expressing TcMSH6 ectopically as a C-terminal fusion
with monomeric Red Fluorescence Protein (mRFP), we were
able to verify that, similar to T. cruzi and T. brucei MSH2
(Grazielle-Silva et al., 2015), TcMSH6 has a nuclear localization
(Figure 4C, upper panel). We confirmed the MSH6 nuclear
localization by generating T. cruzi epimastigotes expressing the
protein with an HA tag inserted in the endogenous msh6 locus
(Figure 4C, lower panel). Using western blot, we showed that
TcMSH6 fused to an HA tag is expressed in epimastigotes as
a protein with the expected molecular weight of 117.4 kDa
(Supplementary Figure 3). Thus, identical nuclear localization
of TcMSH6 was observed using two different approaches, i.e.,
by ectopically expressing the protein fused to mRFP using an
episomal vector or by expressing a HA-tagged protein inserted
in its endogenous genomic locus.
T. cruzi msh6 Null Mutants Display
Impaired MMR and Increased
Susceptibility to Hydrogen Peroxide
To initiate the mismatch repair mechanism, MSH2 must form
a heterodimer with MSH6 or MSH3. To verify if T. cruzi
MSH2 works as a dimer with MSH6 in response to the
oxidative stress, we generated msh6 knockout cell lines using
the CRISPR/Cas9 protocol. Recently, a T. cruzi gene editing
protocol using recombinant Cas9 derived from Staphylococcus
aureus (rSaCas9) expressed in Escherichia coli was described
(Soares Medeiros et al., 2017; Burle-Caldas et al., 2018). We
transfected epimastigotes with two sgRNAs complexed with
rSaCas9 together and a donor sequence fragment. As shown in
Figure 5A, the donor fragment containsmsh6 sequences and the
Neomycin phosphotransferase gene (NeoR) flanked by intergenic
sequences that provide trans-splicing and poly-A addition sites
(HX1_Neo_Gapdh cassette), as well as sequences corresponding
to 5′ and 3′ regions of the msh6 gene. After transfection DNA
fromG418 resistant parasites was verified by PCR analyses.While
Tcmsh6 coding sequence has 3,009 base pairs (bp), when the
msh6 CDS is replaced by the NeoR cassette, the PCR product
using the same primer pair generated a smaller fragment with
2,673 bp (Figure 5B). Figure 5B also showed that without G418
drug selection, in the absence of the Cas9 RNP, no parasites with
disrupted msh6 gene were generated. After transfection with the
Cas9 RNP and donor DNA, only clones with one allele disrupted
were generated. To disrupt the second allele, we performed
a second round of transfection of one heterozygous mutant
FIGURE 5 | Generation of T. cruzi msh6 null mutants. (A) Schematic representation of the strategy to generate Tcmsh6 knockouts. T. cruzi CL Brener WT parasites
were transfected with buffer, recombinant rSaCas9 (in pink), two different sgRNA sequences and a donor construction named msh6_HX1_Neo_Gapdh_msh6 or
donor sequence only. (B) After transfection, genomic DNA was extracted and PCR-amplified using primers to amplify the entire CDS (black arrows mark primer
binding site—left panel). Agarose gel electrophoresis of PCR fragments to evaluate knockout efficiency. Non-interrupted Tcmsh6 CDS results in a PCR fragment of
3,009 bp. CDS interrupted by donor construction results in a PCR fragment of 2,673 bp. (C) Assessing the integration of DNA constructions to delete Tcmsh6. The
panel above each agarose gel represents only one allele of WT or knockout (KO) culture. Black arrows denote regions of the WT or mutated loci complementary to the
different primers. PCR amplifications were carried out to verify the knockout of Tcmsh6 using specific primers annealing in the target gene (P1F and P2R) or in the Neo
(P3R) or Hygro (P4R) resistance genes. PCR products generated using genomic DNA from T. cruzi WT or four KO clones in which Neomycin resistance gene and
Hygromycin resistance have integrated are shown after separation on 1% agarose gels.
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cloned cell line that is G418 resistant. PCR analyses of DNA
extracted from four double resistant cloned cell lines showed
that the 3.009 pb fragment was replaced by the Hygromycin
cassette, which has 3.520 bp and contains the hygromycin
resistance gene flanked by trans-splicing and poly-A addition
signals (HX1_Hygro_Gapdh cassette) as well as 5′ and 3′ msh6
sequences. As shown in Figure 5C the correct insertion of the
NeoR and HygR cassettes, interrupting both msh6 alleles, was
confirmed by PCR-amplification with primers annealing in the
msh6 5′ UTR and CDS (P1F—P2R, see left panel), in the msh6
5′ UTR and in the NeoR gene (P3R or P4R, see middle panel)
and in the msh6 5′ UTR and the HygR gene (P1F and P2R,
right panel). The PCR-amplified msh6 fragment of 1,689 bp was
observed only in WT parasites but not in the four Tcmsh6 null
mutants cell lines. On the other hand, PCR fragments amplified
with the msh6 and NeoR primer of 1.919 bp and with the
msh6 and HygroR of 2,802 bp were only detected with DNA
from transfected cloned cell lines and not with DNA from WT
parasites (Figure 5C).
To evaluate if TcMSH6 knockout affects the MMR capacity
of the mutant cell lines, parasites were treated with MNNG
and compared with treated WT cells. As shown in Figure 6A,
a significant increase in the tolerance to MNNG treatment
was observed in all msh6 mutants, including the Tcmsh6
heterozygous (Tcmsh6+/-) and null mutants (Tcmsh6-/-),
compared to WT parasites. To ask if the phenotype observed
with Tcmsh2 null mutants in response to treatment with H2O2
is also observed in Tcmsh6 mutants, we compared the growth of
WT cells and two cloned heterozygous mutants, as well as two
cloned homozygous msh6 mutants, after treatment for 30min
with 100µM H2O2 and incubating in LIT medium for 72 h. As
shown in Figure 6B Tcmsh6+/- and Tcmsh6-/-mutants are more
susceptible to the treatment with H2O2 thanWT cells. To analyze
the reversion of the msh6 knockout phenotype, we transfected
twoTcmsh6-/- cloned cell lines with the pTREX vector containing
the complete msh6 coding region fused to an HA tag. Western
blot analyses with anti-HA antibody showed the expression of
MSH6::HA in cell extracts derived from transfected cultures
(Supplementary Figure 4). Although no significant differences
in the tolerance to MNNG were observed, both MSH6 re-
expresser cell lines showed reversion of the susceptibility to H2O2
treatment (Figures 6C, D).
FIGURE 6 | Evaluation of susceptibility of T. cruzi msh6 mutants to N-methyl-N’-nitro-N- nitrosoguanidine (MNNG) and H2O2. (A) T. cruzi WT and MSH6 mutants
(Tcmsh6+/- and Tcmsh6-/-) were grown in culture medium with 0µM or 5µM MNNG. Cell viability was measured after 72 h and is plotted as the percentage survival
of the MNNG treated cells relative to untreated cultures. Vertical lines indicate standard deviation. The graph represents the average of two independent experiments
performed in duplicate. (B) T. cruzi epimastigote cells wild type (WT), Tcmsh6+/- (clones 1 and 2) and Tcmsh6-/- (clones 1 and 2) mutants were incubated in the
presence or absence of H2O2 100µM for 30min in PBS 1x and then allowed to grow in LIT medium for 72 h, after which cell viability was determined and plotted as
percentage survival of the treated cells relative to untreated. (C) T. cruzi WT, Tcmsh6-/- and Tcmsh6-/- transfected to express MSH6::HA were grown in culture
medium with 0µM or 5µM MNNG. Cell viability was measured after 72 h and is plotted as the percentage survival of the MNNG treated cells relative to untreated
cultures. Vertical lines indicate standard deviation. The graph represents the average of two independent experiments, each performed in duplicate. (D) T. cruzi WT,
Tcmsh6-/- and Tcmsh6-/- transfected to express MSH6::HA mutants were incubated in the presence or absence of 100µM H2O2 for 30min in PBS 1x and then
allowed to grow in LIT medium for 72 h, after which cell viability was determined and plotted as percentage survival of the treated cells relative to untreated. Data
represent the average of three independent experiments, each performed in duplicate. Vertical lines show standard deviation. ****p < 0.0001, ***p < 0.001, *p < 0.1:
determined by one-way ANOVA with Bonferroni post-test of mutants relative to wild type cells.
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Because we observed that msh6 mutants are more sensitive
to H2O2 treatment, we investigated whether deletion of msh6
gene affects parasite intracellular survival and amastigote
multiplication. Different from T. brucei, T. cruzi has a part of its
life cycle as an intracellular amastigote stage, which must cope
with the generation of ROS by infected cells (Paiva et al., 2018).
We investigated the role of MSH6 in response to the oxidative
stress generated by two different cell types: epithelial cells and
intraperitoneal macrophages extracted from BALB/c mice. Both
cell types, previously attached to a glass coverslip, were infected
with equal numbers of WT and Tcmsh6-/- trypomastigotes
released from infected Vero cells. As shown in Figure 7 no
differences in the infection index were observed between the
WT and Tcmsh6-/- after infection of Vero cells (Figure 7A)
or macrophages (Figure 7B). Supplementary Figure 5 shows
that, for infected Vero cells, we observed no differences
in the number of infected cells (Supplementary Figure 5A)
or in the number of intracellular amastigotes per infected
cells at 24 h or 48 h post-infection (Supplementary Figure 5B).
Similarly, no differences in the number of infected macrophages
(Supplementary Figure 5C), or in the number of intracellular
parasites per infected macrophages (Supplementary Figure 5D),
were observed between WT and Tcmsh6-/-mutants.
DISCUSSION
We have shown previously that the response to oxidative DNA
damage works differently in T. brucei and T. cruzi, and that
this response is dependent on the life cycle stage of each
parasite. A summary of the responses, to the two genotoxic
agents, observed in the different T. brucei and T. cruzi knockout
mutants is provided in Supplementary Table 3. In T. brucei,
MSH2 appears to be directly involved with the response to H2O2
exposure, since loss of MSH2 in BSFs resulted in increased
sensitivity to the oxidative agent, whereas MSH2 loss in PCF
cells resulted in increased tolerance to H2O2. Increased tolerance
to H2O2 exposure was also seen in T. cruzi epimastigote MSH2
null mutants, which also showed increased survival in ROS-
producing macrophages, compared with WT parasites. Similar
to the phenotype observed in other eukaryotes, loss of MSH2
resulted in impaired MMR, both in T. brucei and T. cruzi
mutants, as demonstrated by the increased tolerance to the
alkylator MNNG. Because altered H2O2 tolerance was not
observed in T. brucei BSF or PCF cells lacking MLH1, a protein
that acts downstream from MSH2 in the MMR pathway, we
hypothesized that MSH2 displays a dual role, one as an MMR
component and a second role as a factor involved in the response
to oxidative stress, in a way that is independent of MLH1. We
have also hypothesized that the increased oxidative resistance of
msh2 null mutants generated in procyclic T. brucei and in T. cruzi
epimastigotes may be due to adaptation of the insect stages of
these parasites to MSH2 loss. This hypothesis is corroborated
by the necessity of having a gradual process to obtain T. cruzi
epimastigotes mutants with both msh2 alleles deleted. We have
also speculated that the differences observed in the phenotypic
outcomes observed in T. brucei MSH2 mutants generated in
PCFs may be explained by the greater burden of oxidative stress
that the parasites are submitted during their insect life cycle
stages (Grazielle-Silva et al., 2015).
Here we asked whether the role played by T. brucei and
T. cruzi MSH2 in the oxidative stress response is MMR-
independent or if MSH2 acts together with other MMR proteins
in a non-canonical pathway. Toward that, we generated T.
brucei BSF mutants with deleted msh3 or msh6, and T.
cruzi epimastigotes msh6 null mutants. As indicated above,
studies with T. brucei mlh1 knockout cell lines have already
indicated that this MMR protein is not involved in the
oxidative stress response (Grazielle-Silva et al., 2015). Initially,
co-immunoprecipitation assays followed by mass spectrometry
showed that T. brucei MSH2 physically interacts with MSH3
and MSH6 in both BSF and PCF forms, though no other
proteins were identified in the co-immunoprecipitation complex
that contains MSH2. We also showed that, MSH2 interacts
with MSH6 in T. cruzi epimastigotes. We have repeated the
co-immunoprecipitation assay after treatment with MNNG or
FIGURE 7 | Assessment of T. cruzi msh6 null mutants infectivity in vitro. (A) T. cruzi trypomastigote cells released by Vero cells infected with either WT or with two
cloned cell lines of Tcmsh6-/- mutants were counted and equal numbers were used to infect Vero cells attached to glass coverslips. (B) Infection of intraperitoneal
macrophages extracted from Balb/C mice with trypomastigotes released from infected Vero cells. Twenty-four and forty-eight hours post infection the infection index
was estimated. Infection index = percentage of infected cells × mean number of parasites per infected cells. Values are expressed as means ± SD of one
representative experiment performed in triplicate. Ns indicates no significant difference: two-way ANOVA with Bonferroni post-test of knockout mutants relative to wild
type.
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H2O2, but no novel interactions with MSH2 could be identified
(data not shown).
In contrast to msh3 knockout parasites, T. brucei msh6 null
mutants, but not the heterozygous mutants, showed impaired
MMR, since tolerance to MNNG was increased in msh6-/- BSFs
compared to WT BSF, similar to previous observation in BSF
msh2-/- mutants (Bell andMcCulloch, 2003). O6meG lesions can
be formed after DNA alkylation byMNNG and attempts to repair
this damage leads to futile repair cycles that ends up signaling or
causing cell death (Gupta et al., 2018). A similar phenotype was
observed withT. cruzi msh6 null mutants afterMNNG treatment.
These results thus indicate that the absence of MSH6 results in
non-functionalMMR in both parasites. Although we showed that
MSH3 is a binding partner to MSH2 in both T. brucei BSFs and
PCFs, MSH3 does not seem to be involved in the response to this
alkylating damage. What substrates the T. brucei MSH2-MSH3
heterodimer acts on remain to be determined.
After showing evidence that the lack of MSH6 affects the
MMR pathway in both parasites, we showed that in T. brucei
BSFs, MSH3, andMSH6 seems not to be involved in the oxidative
stress response, using the same experimental conditions applied
previously withmsh2 null mutants. The effect of disruptingmsh3
and msh6 genes in PCFs still needs to be verified. Also, to test
the hypothesis that T. brucei MSH2 is involved in the response
to oxidative DNA damage in a way that is independent of other
MMR components, a double mutant Tbmsh6-/-msh3-/- needs to
be generated to compare the differences in the response to H2O2
treatment with WT parasites. With a double msh3/msh6 mutant,
we would be able to exclude the possibility that, in the absence of
MSH6, MSH2 may still form a complex with MSH3 and provide
a role in tackling oxidative stress.
Nevertheless, the lack of sensitivity of msh6 null mutants to
oxidative damage adds detail to our hypothesis that MSH2 may
provide a unique function in this role, as initially shown by our
previous studies showing that T. brucei BSF msh2 null mutants
complemented with T. cruzi msh2 have restored their capacity to
respond to oxidative stress response, but have not restored MMR
function (Machado-Silva et al., 2008).
The results obtained with the analyses of T. brucei mutants
are in sharp contrast with the effect of disrupting the msh6 gene
in T. cruzi epimastigotes, which showed a clear effect on the
susceptibility to H2O2 treatment. Besides increased susceptibility
to oxidative stress, T. cruzi msh6-/- mutants display increased
resistance to MNNG, suggesting impaired MMR. Although we
were able to demonstrate that re-expressing MSH6 causes the
sensitivity to H2O2 to be reverted, we do not see a significant
reversion of the tolerance to MNNG, which may due to an
imbalanced expression of MSH6 and altered dynamics of MSH2-
MSH6 function during MMR. The effect observed with T. cruzi
msh6 mutants is in line with the expected role of MSH6 as a
MSH2 partner during the initial steps of the MMR. However,
because in T. cruzi epimastigotes msh2 knockouts presented an
increased tolerance to H2O2 treatment, whereas MSH6 deficient
cells were more sensitive to the same treatment, the role of MSH6
as a MSH2 partner in the response to oxidative stress is unclear.
The fact that re-expression of MSH6 in the msh6 knockout
mutants reverts the H2O2 susceptibility further corroborates its
role as a component of the DNA repair machinery involved with
the oxidative stress response. It is possible that the generation of
T. cruzi msh6 deletions with the highly efficient CRISPR/Cas9
protocol makes it impossible for an adaptation process that we
speculated that may have resulted from the msh2 disruption
obtained with the classical HR-based protocol, which has a slower
selection of drug resistant parasites. Thus, in contrast to themsh2
mutants, the rapid generation of msh6-/- may not have allowed
the mutated parasites to adapt their metabolism to cope with
the oxidative stress response in the absence of a MMR protein
(Grazielle-Silva et al., 2015). Recent evidence suggests that an
oxidative environment is favorable for intracellular parasite
survival and infection (Paiva et al., 2018). The parasite has an
arsenal of enzymes to assure infection and keeps homeostasis
while going into different redox environments inside the hosts
(Mesías et al., 2019). How this plasticity is achieved is still unclear.
Long-term cultivation of T. cruzi induces mutational events. This
frequency is increased when parasites are cultivated in sub-lethal
doses of H2O2 (Torres-Silva et al., 2018). In trypanosomatids,
MMR proteins might have an additional role in recognizing
DNA oxidative damage and act as signaling molecules. It is
possible that after long-term cultivation of T. cruzi msh6-/- in
sub-lethal doses of H2O2 parasites adapted to the oxidative stress,
such as T. cruzi msh2-/- could be obtained. It should be also
considered that, since MSH2 forms pairs with MSH3 or MSH6,
the formation of the heterodimermay be required for the stability
of MSH2 and loss of MSH6 could lead to a destabilization and
a direct impact on the levels of MSH2 protein. Consequently,
in a model where the oxidative damage response mechanism
requires MSH2 independently of other MMR proteins, the lack
of MSH6 may have an indirect effect by reducing MSH2 half-life.
Taken together, our data suggest that MSH2, but not MSH6, has
a predominant role in the oxidative stress response in T. cruzi.
The observation showing no differences in the survival rates
after infection of two different cell types with T. cruzi msh6-/-,
whereas a clear difference was observed when macrophages
were infected with msh2 mutants compared to WT parasites
(Grazielle-Silva et al., 2015), also points toward a distinct role
between these two MMR components in the oxidative stress
response of T. cruzi.
With the current data, one cannot conclude whether T. cruzi
MSH6 acts together with MSH2 to recognize oxidative damage,
or if MSH6 acts by maintaining the stability of the MutSα
heterodimer, which may be also important for T. brucei MSH2.
In a scenario of a non-canonical MMR function in the oxidative
stress response it is also possible that, even though MSH6 in
T. cruzi is also involved in the oxidative stress response, by
recognizing DNA damage through MutSα heterodimer, MSH2
may have a more predominant role with the recruitment of
proteins related to damage signaling, such as ATR (Wang and
Qin, 2003; Stojic et al., 2004; Yan et al., 2014). In Leishmania
major has been demonstrated that ATR is involved in the
oxidative stress response (da Silva et al., 2018). Clearly, the
involvement of other signaling molecules in the oxidative stress
response in T. cruzi and T. brucei needs to be further investigated.
Although it is not surprising that the oxidative stress response
works differently in T. cruzi and T. brucei, since these parasites
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have diverged around 100 million years ago (Stevens et al.,
1999), the additional studies needed to clarify this response
in these two important human pathogens may still bring new
interesting surprises.
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